Dr Lourdes G Bahamonde, DO | |
7643 Atlantic Ave, Cudahy, CA 90201-5019 | |
(213) 373-1265 | |
Not Available |
Full Name | Dr Lourdes G Bahamonde |
---|---|
Gender | Female |
Speciality | Internal Medicine |
Experience | 18 Years |
Location | 7643 Atlantic Ave, Cudahy, California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134381619 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RG0100X | Internal Medicine - Gastroenterology | 254878 (New York) | Secondary |
207RG0100X | Internal Medicine - Gastroenterology | 20A13517 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Huntington Memorial Hospital | Pasadena, CA | Hospital |
Entity Name | Lourdes G Bahamonde Do Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609533587 PECOS PAC ID: 2567854367 Enrollment ID: O20220127001335 |
News Archive
Sepsis represents a serious complication of infection and is one of the leading causes of death and critical illness worldwide due in part to the lack of effective therapies. A report in the American Journal of Pathology provides evidence from both mouse and human studies that SHARPIN, a protein involved in regulating inflammation, has anti-septic effects. These findings may spur development of novel sepsis treatments.
The drug bevacizumab, also known by the trade name Avastin, shrinks tumors briefly in patients with an aggressive brain cancer known as glioblastoma multiforme, but then they often grow again and spread throughout the brain for reasons no one previously has understood. Now, Mayo Clinic researchers have found out why this happens.
Rexahn Pharmaceuticals, Inc. announced today that it has completed its previously announced Registered Direct Offering of common stock and warrants. Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (NasdaqGM: RODM), acted as the exclusive placement agent for this transaction.
State Medicaid programs are facing trouble and looking for solutions. Meanwhile, California regulators face down medical wait times and local political candidates face the health care issue during their short campaign season.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Lourdes G Bahamonde, DO 147 N Mayflower Ave, Monrovia, CA 91016-2005 Ph: (516) 526-9192 | Dr Lourdes G Bahamonde, DO 7643 Atlantic Ave, Cudahy, CA 90201-5019 Ph: (213) 373-1265 |
News Archive
Sepsis represents a serious complication of infection and is one of the leading causes of death and critical illness worldwide due in part to the lack of effective therapies. A report in the American Journal of Pathology provides evidence from both mouse and human studies that SHARPIN, a protein involved in regulating inflammation, has anti-septic effects. These findings may spur development of novel sepsis treatments.
The drug bevacizumab, also known by the trade name Avastin, shrinks tumors briefly in patients with an aggressive brain cancer known as glioblastoma multiforme, but then they often grow again and spread throughout the brain for reasons no one previously has understood. Now, Mayo Clinic researchers have found out why this happens.
Rexahn Pharmaceuticals, Inc. announced today that it has completed its previously announced Registered Direct Offering of common stock and warrants. Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (NasdaqGM: RODM), acted as the exclusive placement agent for this transaction.
State Medicaid programs are facing trouble and looking for solutions. Meanwhile, California regulators face down medical wait times and local political candidates face the health care issue during their short campaign season.
› Verified 3 days ago
Dr. Marco A Martinez, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 4566 Florence Ave, Suite # 5, Cudahy, CA 90201 Phone: 323-771-7466 Fax: 323-771-4920 |